Absalom, Nathan L.
The University of Sydney · Filadelfia · Western Sydney University
3 papers on CoChatORCID 0000-0002-6084-5991
Most cited papers
- Verified
Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies
Absalom, N. L., Liao, V. W. Y., Johannesen, K. M. H., Gardella, E., Jacobs, J., Lesca, G., Gokce-Samar, Z., Arzimanoglou, A., Zeidler, S., Striano, P., et al. (2022) · Nature Communications
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 89
- Verified
Kavain, the major constituent of the anxiolytic kava extract, potentiates GABAA receptors: Functional characteristics and molecular mechanism
Chua, H. C., Christensen, E. T. H., Hoestgaard-Jensen, K., Hartiadi, L. Y., Ramzan, I., Jensen, A. A., Absalom, N. L., & Chebib, M. (2016) · PLoS ONE
Medicinal Plant Extracts EffectsNeuroscience and Neuropharmacology Research
Cited by 87
- Verified
Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants
Mohammadi, N. A., Ahring, P. K., Yu Liao, V. W., Chua, H. C., Ortiz de la Rosa, S., Johannesen, K. M., Michaeli-Yossef, Y., Vincent-Devulder, A., Meridda, C., Bruel, A.-L., et al. (2024) · eBioMedicine
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free